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CO M M E N TA R Y

Diaphragm weakness and mechanical ventilation what’s the critical issue?
Leigh Ann Callahan* and Gerald S Supinski
See related research by Hermans et al., http://ccforum.com/content/14/4/R127

Abstract
While animal studies indicate that controlled
mechanical ventilation (MV) induces diaphragm
weakness and myofiber atrophy, there are no data in
humans that confirm MV per se produces diaphragm
weakness. Whether or not diaphragm weakness
results from MV, sepsis, corticosteroids, hyperglycemia,
or a combination of these factors, however, is not
the most important issue raised by the recent study
from Hermans and colleagues. This study makes
an important contribution by providing additional
evidence that many critically ill patients have profound
diaphragm weakness. If diaphragm weakness of this
magnitude is present in most mechanically ventilated
patients, a strong argument can be made that
respiratory muscle weakness is a major contributor to
respiratory failure.

Numerous animal studies indicate that controlled mechanical ventilation (MV) induces diaphragm weakness and
myoﬁber atrophy, but no data in humans conﬁrm MV per
se produces diaphragm weakness. In their recent publication, Hermans and colleagues [1] used an objective
nonvolitional technique of bilateral anterolateral magnetic stimulation of the phrenic nerves to measure twitch
transdiaphragmatic pressure (TwPdi) and assessed the
degree of diaphragm weakness in ten critically ill
mechanically ventilated patients. Importantly, they found
an average TwPdi value of 11.5 ± 3.9 cm water, which
represents a 70% reduction in diaphragm strength when
compared to normal individuals. In their analysis, the
authors suggest that duration of MV is associated with
decreased diaphragm force generation. This interpretation, however, may be misleading. Importantly, nine of
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the ten patients in their study were septic and eight out of
ten received corticosteroids. Moreover, no information
regarding glucose control is included. Since sepsis,
corticosteroid use and hyperglycemia are major risk
factors for acquired weakness [2,3], it seems plausible
that these conditions also contributed to the diaphragm
weakness observed.
Whether or not diaphragm weakness results from
sepsis, respiratory muscle unloading from MV, corticosteroids, hyperglycemia, or a combination of these
factors, however, is not the most important issue raised
by this study. Hermans and colleagues [1] should be
congratulated because their study makes an important
contribution by providing additional evidence that many
critically ill patients have profound diaphragm weakness
[4,5]. If diaphragm weakness of this magnitude is present
in most mechanically ventilated patients, a strong argument can be made that respiratory muscle weakness is a
major contributor to respiratory failure.
Consider this - mechanical ventilators are not artiﬁcial
lungs but simply machines that substitute for the
respiratory pump. The fact is that the respiratory pump
does not have an unlimited capacity; if it did, theoretically, some patients would require augmented oxygen
delivery and/or end expiratory pressure but none would
require MV. For patients with normal respiratory muscle
function, respiratory failure usually occurs when the
respiratory workload becomes too high for the normal
pump to maintain ventilation. In principal, any reduction
in pump function below normal should increase the
propensity for respiratory failure to develop, with the
level of respiratory workload required to induce respiratory failure directly related to the level of pump function.
Speciﬁcally, the lower the pump function, the lower the
respiratory workload required to induce respiratory
failure. If this concept is correct, the level of respiratory
muscle dysfunction reported by Hermans and colleagues
should be a major contributor to respiratory failure.
Unless the patient has a known neuromuscular
disorder, critical care physicians often overlook diaphragm weakness as an important factor contributing to
respiratory failure and weaning diﬃculties in a signiﬁcant
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number of patients. We focus on improving lung function, perhaps because conceptually this is easier to
understand, easier to assess using chest radiographs, and,
for the most part, the treatment options are relatively
straightforward. On the other hand, if we recognize that
diaphragm weakness is present, what can we do?
Regrettably, the current approach to diaphragm weakness
in critically ill patients is similar to the approach to
pulmonary hypertension 30 years ago. Physicians once
believed pulmonary hypertension was extremely rare,
and there were no treatments. Today, we recognize that
pulmonary hypertension is more prevalent, we have
better tools to diagnose this problem, and we have a
growing ensemble of pharmacological agents to treat
patients with this disorder. To make such progress in
dealing with the problem of respiratory muscle dysfunction in critically ill patients, we need better diagnostic
tools, a better understanding of the pathophysiology of
this disorder and, most importantly, we need to develop
rational, speciﬁc and eﬀective treatments. Once these
goals are met, we may be able to substantially shorten the
duration of MV in ICU patients and improve long-term
outcomes in this growing population of patients.
Abbreviations
MV = mechanical ventilation; TwPdi = twitch transdiaphragmatic pressure.

Page 2 of 2

Competing interests
The authors declare that they have no competing interests.
Acknowledgements
Our work is supported by NIH grants R01 HL80609 (LAC), R01 HL80429 (GS),
R01 HL081525 (GS), RC1 HL100239 (GS).
Published: 4 August 2010
References
1. Hermans G, Agten A, Testelmans D, Decramer M, Gayan-Ramirez G: Increased
duration of mechanical ventilation is associated with decreased
diaphragmatic force: a prospective observational study. Crit Care 2010,
14:R127.
2. De Jonghe B, Lacherade JC, Sharshar T, Outin H: Intensive care unit-acquired
weakness: risk factors and prevention. Crit Care Med 2009, 37:S309-315.
3. Griffiths RD, Hall JB: Intensive care unit-acquired weakness. Crit Care Med
2010, 38:779-787.
4. Watson AC, Hughes PD, Louise Harris M, Hart N, Ware RJ, Wendon J, Green M,
Moxham J: Measurement of twitch transdiaphragmatic, esophageal, and
endotracheal tube pressure with bilateral anterolateral magnetic phrenic
nerve stimulation in patients in the intensive care unit. Crit Care Med 2001,
29:1325-1331.
5. Laghi F, Cattapan SE, Jubran A, Parthasarathy S, Warshawsky P, Choi YS, Tobin
MJ: Is weaning failure caused by low-frequency fatigue of the diaphragm?
Am J Respir Crit Care Med 2003, 167:120-127.

doi:10.1186/cc9189
Cite this article as: Callahan LA, Supinski GS: Diaphragm weakness and
mechanical ventilation - what’s the critical issue? Critical Care 2010, 14:187.

